JP2022550454A5 - - Google Patents
Info
- Publication number
- JP2022550454A5 JP2022550454A5 JP2022520428A JP2022520428A JP2022550454A5 JP 2022550454 A5 JP2022550454 A5 JP 2022550454A5 JP 2022520428 A JP2022520428 A JP 2022520428A JP 2022520428 A JP2022520428 A JP 2022520428A JP 2022550454 A5 JP2022550454 A5 JP 2022550454A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- use according
- arm region
- nucleic acid
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962909321P | 2019-10-02 | 2019-10-02 | |
| US62/909,321 | 2019-10-02 | ||
| PCT/US2020/053606 WO2021067480A1 (en) | 2019-10-02 | 2020-09-30 | Compositions and methods for treatment of hepatitis b virus infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022550454A JP2022550454A (ja) | 2022-12-01 |
| JP2022550454A5 true JP2022550454A5 (https=) | 2023-10-10 |
Family
ID=75337516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520428A Pending JP2022550454A (ja) | 2019-10-02 | 2020-09-30 | Ｂ型肝炎ウイルス感染の治療のための組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220241314A1 (https=) |
| EP (1) | EP4037706A4 (https=) |
| JP (1) | JP2022550454A (https=) |
| CN (1) | CN114502194A (https=) |
| WO (1) | WO2021067480A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11679163B2 (en) | 2019-09-20 | 2023-06-20 | Hdt Bio Corp. | Compositions and methods for delivery of RNA |
| KR20220156933A (ko) | 2020-03-23 | 2022-11-28 | 에이치디티 바이오 코포레이션 | Rna의 전달을 위한 조성물 및 방법 |
| WO2021226129A1 (en) * | 2020-05-04 | 2021-11-11 | Neuralexo, Inc. | Small molecule activators of interferon regulatory factor 3 and methods of use thereof |
| WO2023048760A1 (en) | 2021-09-22 | 2023-03-30 | Hdt Bio Corp. | Rna vaccines against infectious diseases |
| JP2024535354A (ja) | 2021-09-22 | 2024-09-30 | エイチディーティー バイオ コーポレーション | がん治療組成物およびその使用 |
| EP4404919A4 (en) | 2021-09-22 | 2025-08-20 | Hdt Bio Corp | DRIED NANOPARTICLE COMPOSITIONS |
| CA3232719A1 (en) | 2021-09-22 | 2023-03-30 | Steven Gregory REED | Sars-cov-2 rna vaccine compositions and methods of use |
| WO2025040743A1 (en) | 2023-08-22 | 2025-02-27 | Univerza V Ljubljani | Conjugated tlr7 and rig-i agonists |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013267209B2 (en) * | 2012-06-01 | 2017-02-02 | Baruch S. Blumberg Institute | Modulation of hepatitis B virus cccDNA transcription |
| WO2014074628A1 (en) * | 2012-11-08 | 2014-05-15 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Compounds for treating hiv and methods for using the compounds |
| US9775894B2 (en) * | 2013-07-09 | 2017-10-03 | University Of Washington Through Its Center For Commercialization | Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling |
| JP6419313B2 (ja) * | 2014-05-09 | 2018-11-07 | キネタ・インコーポレイテッドＫｉｎｅｔａ， Ｉｎｃ． | 抗ウイルスの化合物、医薬組成物およびその使用方法 |
| WO2016164619A2 (en) * | 2015-04-07 | 2016-10-13 | Spring Bank Pharmaceuticals, Inc. | Compositions and methods for the treatment of hbv infection |
| KR20190057277A (ko) * | 2016-06-24 | 2019-05-28 | 에모리 유니버시티 | B형 간염 바이러스 치료용 포스포아미데이트 |
| EP3634431A4 (en) * | 2017-05-31 | 2021-06-23 | Arbutus Biopharma Corporation | THERAPEUTIC COMPOSITIONS AND METHODS OF TREATMENT FOR HEPATITIS B |
| WO2019152884A1 (en) * | 2018-02-02 | 2019-08-08 | University Of Washington | Compositions and methods for inducing tripartite motif-containing protein 16 (trim16) signaling |
-
2020
- 2020-09-30 WO PCT/US2020/053606 patent/WO2021067480A1/en not_active Ceased
- 2020-09-30 JP JP2022520428A patent/JP2022550454A/ja active Pending
- 2020-09-30 EP EP20870757.0A patent/EP4037706A4/en active Pending
- 2020-09-30 CN CN202080069643.5A patent/CN114502194A/zh active Pending
-
2022
- 2022-03-31 US US17/710,783 patent/US20220241314A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022550454A5 (https=) | ||
| CA2470255A1 (en) | N4-acylcytosine nucleosides for treatment of viral infections | |
| JP2017521433A5 (https=) | ||
| JP2018500372A5 (https=) | ||
| US20060074035A1 (en) | Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infections | |
| US20110207690A1 (en) | Compositions and methods for treating viral infections | |
| PL409123A1 (pl) | Związki, ich zastosowanie i kompozycje do leczenia wirusowego zapalenia wątroby typu C | |
| JP2022522312A5 (https=) | ||
| BRPI0616738A2 (pt) | 4'-nucleosìdeos modificados como agentes antivirais | |
| JP2008255121A (ja) | 抗ｂ型肝炎ウイルス活性を有するヌクレオシド | |
| JP2025509438A5 (https=) | ||
| JP2021090458A5 (https=) | ||
| Choi et al. | Structure− activity relationships of (e)-5-(2-bromovinyl) uracil and related pyrimidine nucleosides as antiviral agents for herpes viruses | |
| JP2018538302A5 (https=) | ||
| JP2024534502A5 (https=) | ||
| CN114533739B (zh) | 核苷类似物在制备预防或治疗胃肠道疾病药物中的应用 | |
| JP2025500860A5 (https=) | ||
| JP2023543898A5 (https=) | ||
| JP2023552274A5 (https=) | ||
| JP2008528624A5 (https=) | ||
| CA2287370A1 (en) | Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides | |
| JP5744003B2 (ja) | 抗ウイルス化合物を調製する方法 | |
| JP2022519764A5 (https=) | ||
| JP2001335592A5 (https=) | ||
| JP2014532636A5 (https=) |